ORIGINAL PAPER
Evaluation of thyroid hormones and thyroid-stimulating hormone levels in critically ill full-term newborns
1
Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt
2
Department of Pediatrics, National Research Centre, Cairo, Egypt
3
Department of Chemical Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt
Submission date: 2021-10-20
Final revision date: 2022-01-25
Acceptance date: 2022-02-09
Publication date: 2022-06-10
Pediatr Pol 2022;97(2):89-94
KEYWORDS
TOPICS
ABSTRACT
Aim of the study:
This study aimed to define the thyroid hormone characteristics in full-term critically ill neonates versus healthy neonates to evaluate the incidence of the euthyroid sick syndrome (ESS).
Material and methods:
The present case-control study recruited 30 neonates presenting with manifestations of severe critical illness and a similar number of healthy controls. Patients were subjected to TT3, TT4, TSH, and FT4 testing.
Results:
For the whole group of cases at the first sample the TT3-1 level was significantly lower than that of controls (85.63 ±33.380 ng/dl, 115.03 ±30.310 ng/dl, respectively) with a highly significant difference. The TT4-1 in cases on admission showed a highly significant difference to that of controls (7.607 ±2.2789 µg/dl, 11.219 ±2.088 µg/dl, respectively) (p < 0.01). TSH-1 in cases on admission was higher (6.573 ±6.6766 µIU/ml) than that of controls (3.964 ±4.5748 µIU/ml), but this did not show a significant difference (p > 0.05). In the second sample (5-6 days after the beginning of illness), TT3-2 (104.23 ±42.592 ng/dl) was still significantly less than that of controls (115.03 ±30.310 ng/dl), with a p-value < 0.05. TT4-2 (8.20 ±2.646), and still significantly lower than that of controls (11.219 ±2.088 µg/dl) with p-value < 0.05. TSH-2 in cases was higher (5.57 ±5.836 µIU/ml) than that of controls (3.964 ±4.5748 µIU/ml) with no significant difference (p > 0.05).
Conclusions:
Critical illnesses are hallmarked by changes in circulating thyroid hormone parameters in full-term neonates with low TT3 concentrations in the absence of elevated TSH. The critically ill cases had a worse thyroid hormonal profile from the beginning of the disease until death compared with those who survived.
This study aimed to define the thyroid hormone characteristics in full-term critically ill neonates versus healthy neonates to evaluate the incidence of the euthyroid sick syndrome (ESS).
Material and methods:
The present case-control study recruited 30 neonates presenting with manifestations of severe critical illness and a similar number of healthy controls. Patients were subjected to TT3, TT4, TSH, and FT4 testing.
Results:
For the whole group of cases at the first sample the TT3-1 level was significantly lower than that of controls (85.63 ±33.380 ng/dl, 115.03 ±30.310 ng/dl, respectively) with a highly significant difference. The TT4-1 in cases on admission showed a highly significant difference to that of controls (7.607 ±2.2789 µg/dl, 11.219 ±2.088 µg/dl, respectively) (p < 0.01). TSH-1 in cases on admission was higher (6.573 ±6.6766 µIU/ml) than that of controls (3.964 ±4.5748 µIU/ml), but this did not show a significant difference (p > 0.05). In the second sample (5-6 days after the beginning of illness), TT3-2 (104.23 ±42.592 ng/dl) was still significantly less than that of controls (115.03 ±30.310 ng/dl), with a p-value < 0.05. TT4-2 (8.20 ±2.646), and still significantly lower than that of controls (11.219 ±2.088 µg/dl) with p-value < 0.05. TSH-2 in cases was higher (5.57 ±5.836 µIU/ml) than that of controls (3.964 ±4.5748 µIU/ml) with no significant difference (p > 0.05).
Conclusions:
Critical illnesses are hallmarked by changes in circulating thyroid hormone parameters in full-term neonates with low TT3 concentrations in the absence of elevated TSH. The critically ill cases had a worse thyroid hormonal profile from the beginning of the disease until death compared with those who survived.
REFERENCES (29)
1.
Eerdekens A, Naulaers G, Ortibus E, et al. Evolution of circulating thyroid hormone levels in preterm infants during the first week of life: perinatal influences and impact on neurodevelopment. J Pediatr Endocrinol Metab 2019; 32: 597-606.
2.
Fliers E, Boelen A. An update on non-thyroidal illness syndrome. J Endocrinol Invest 2021; 44: 1597-1607.
3.
Jacobs A, Derese I, Vander Perre S, et al. Non-thyroidal illness syndrome in critically ill children: prognostic value and impact of nutritional management. Thyroid 2019; 29: 480-492.
4.
De Luca R, Davis PJ, Lin HY, et al. Thyroid hormones interaction with immune response, inflammation and non-thyroidal illness syndrome. Front Cell Dev Biol 2021; 8: 614030.
5.
Haas NA, Camphausen CK, Kececioglu D. Clinical review: thyroid hormone replacement in children after cardiac surgery – is it worth a try? Crit Care 2006; 10: 213.
6.
Xu J, Wang L. Low T3 syndrome as a predictor of poor prognosis in patients with pyogenic liver abscess. Front Endocrinol (Lausanne) 2019; 10: 541.
7.
Chen Y, Chang J, Yin R, et al. Diagnosis and treatment of low T3 syndrome in neurocritical patients. J Clin Pharm Ther 2020; 45: 759-766.
8.
Brinker M, Dumas B, Visser T, et al. Thyroid function and outcome in children who survived meningococcal septic shock. Intensive Care Med 2005; 31: 970-976.
9.
Lodha R, Vivekanandhan S, Sarthi M, et al. Thyroid function in children with sepsis and septic shock. Acta Paediatr 2007; 96: 406-409.
10.
Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 1996; 312: 1132-1133.
11.
De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin 2006; 22: 57-86.
12.
Golombek SG. Nonthyroidal illness syndrome and euthyroid sick syndrome in intensive care patients. Semin Perinatol 2008; 32: 413-418.
13.
Richardson DK, Gray JE, McCormick MC, et al. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatrics 1993; 91: 617-623.
14.
Goldsmit GS, Valdes M, Herzovich V, et al. Evaluation and clinical application of changes in thyroid hormone and TSH levels in critically ill full-term newborns. J Perinat Med 2011; 39: 59-64.
15.
Vasudevan A, Malhotra A, Lodha R, Kabra SK. Profile of neonates admitted in pediatric ICU and validation of Score for Neonatal Acute Physiology (SNAP). Indian Pediatr 2006; 43: 344-348.
16.
Sutton L, Bajuk B, Berry G, et al. Reliability of the SNAP (score of neonatal acute physiology) data collection in mechanically ventilated term babies in New South Wales, Australia. Acta Paediatr Int J Paediatr 2002; 91: 424-429.
17.
Lim DJ, Herring MK, Leef KH, et al. Hypothyroxinemia in mechanically ventilated term infants is associated with increased use of rescue therapies. Pediatrics 2005; 115: 406-410.
18.
Paul DA, MacKley A, Yencha EM. Thyroid function in term and late preterm infants with respiratory distress in relation to severity of illness. Thyroid 2010; 20: 189-194.
19.
Economidou F, Douka E, Tzanela M, et al. Thyroid function during critical illness. Hormones (Athens) 2011; 10: 117-124.
20.
Hemmati F, Pishva N. Evaluation of thyroid status of infants in the intensive care setting. Singapore Med J 2009; 50: 875-878.
21.
Larson C, Hermos R, Delaney A, et al. Risk factors associated with delayed thyrotropin elevations in congenital hypothyroidism. J Pediatr 2003; 143: 587-591.
22.
Shih JL, Agus MSD. Thyroid function in the critically ill newborn and child. Curr Opin Pediatr 2009; 21: 536-540.
23.
Suvarna JC, Fande CN. Serum thyroid hormone profile in critically III children. Indian J Pediatr 2009; 76: 1217-1221.
24.
Dimmick S, Badawi N, Randell T. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane Database Syst Rev 2004; (3): CD004220.
25.
Haas NA, Camphausen CK. Triiodothyronine in neonatal heart surgery: Looking for an answer. J Thoracic Cardiovasc Surg 2006; 131: 505-506.
26.
Angelousi AG, Karageorgopoulos DE, Kapaskelis AM, Falagas ME. Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: A systematic review. Eur J Endocrinol 2011; 164: 147-155.
27.
Dehghani SM, Haghighat M, Eghbali F, et al. Thyroid hormone levels in children with liver cirrhosis awaiting a liver transplant. Exp Clin Transplant 2013; 11: 150-153.
28.
Meyer S, Schuetz P, Wieland M, et al. Low triiodothyronine syndrome: A prognostic marker for outcome in sepsis? Endocrine 2011; 9: 167-174.
29.
LaFranchi SH. Thyroid function in preterm/low birth weight infants: impact on diagnosis and management of thyroid dysfunction. Front Endocrinol (Lausanne) 2021; 12: 666207.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
